Xunming Bio secures $100M Series B; capital floods back into AI drug discovery

According to an exclusive report by Dark Waves, AI drug discovery company Aureka recently completed a Series B financing totaling $100 million. It has been just over three months since they disclosed their $35 million Series A+ round.